Heart And Lung Transplant Patients May No Longer Need Biopsies A...

Courtesy ScienceDaily Wed, 04/09/2008 - 22:00

New data suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize transplant patient care.

Non-invasive testing using gene-based blood or urine could offer transplant patients personalized care and medication and may replace the need for costly, invasive biopsy procedures that can be risky for patients.

More related items

Cutting The Cord To Determine Babies' Health Risk...
Despite the well-known dangers of first- and secondhand smoke, an estimated ten percent of pregnant women in the US are smokers. Now, in the first study of its kind, a team of researchers has...

DFMO may affect Barrett's esophagus
(American Association for Cancer Research) Pilot study results suggest that difluoromethylornithine can modulate biomarkers of cell proliferation in patients with Barrett's esophagus and...

Detecting Early Forms Of Cancer By Analyzing...
Scientists have developed a system which can pinpoint potential "biomarkers" of early forms of cancer, by looking at structures of specific sugar molecules which are attached either to...

HP 50g Graphing Calculator (F2229AA#ABA)
If you're a math, science, or engineering professional?or a serious college student?don't leave home without it! HP's most powerful new graphing calculator. The 50G supplies you with...

Kitchen Mysteries: Revealing the Science of Cooking...
An international celebrity and founder of molecular gastronomy, or the scientific investigation of culinary practice, Herv& eacute; This is known for his ground-breaking research into the...